The Percutaneous Transmural Arterial Bypass -1 Study (Post Approval Registry)

Enrolling by invitation

Conditions studied: Peripheral Arterial Disease, Symptomatic Femoropopliteal Lesions

In brief

The purpose of this post-market surveillance study will be to evaluate the real-world use of the DETOUR System in treated patients with symptomatic femoropopliteal lesions from 200 mm to 460 mm in length with chronic total occlusions (100 mm to 425 mm) or diffuse stenosis \> 70% who may be considered suboptimal candidates for surgical or alternative endovascular treatments.

Key facts

Study ID

NCT06315023

Run by

Endologix

People needed

450

Starts

2023-10-06

Expected to finish

2032-06-07

Last updated by the study team

2026-05-12

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Salinas Valley Memorial Hospital — Salinas, California, United States
• University of Connecticut — Storrs, Connecticut, United States
• Medstar Washington Hospital Center — Washington D.C., District of Columbia, United States
• Delray Medical Center — Delray Beach, Florida, United States
• Beth Isreal Deaconess Medical Center — Boston, Massachusetts, United States
• Saint Luke's Hospital of Kansas City — Kansas City, Missouri, United States
• NYU Langone Medical Center — New York, New York, United States
• Cleveland Clinic Main Campus — Cleveland, Ohio, United States
• University of Pennsylvania — West Chester, Pennsylvania, United States
• Main Line Health — Wynnewood, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.